Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens Forms Molecular Imaging Unit

By HospiMedica staff writers
Posted on 28 Jun 2005
Siemens Medical Solutions (Erlangen, Germany)has announced that it has formed a new division called Siemens Medical Solutions Molecular Imaging, which combines its nuclear medicine operations with CTI Molecular Imaging, Inc. (Culver City, CA, USA), a leading developer of positron emission tomography (PET) imaging equipment and services.

CTI is a wholly owned subsidiary of Siemens Medical Solutions, acquired by Siemens in May 2005 in a transaction valued at around U.S.$1 billion. With this acquisition and the formation of a division centered on PET and single photon emission computed tomography (SPECT)-based molecular imaging technologies, Siemens strengthens its dedication to molecular imaging development, technologic innovation, and the creation of dynamic new technologies that will update the diagnosis and treatment of disease. This includes the development and distribution of molecular biomarkers, preclinical imaging for research and pharmaceuticals, and application and post-processing for molecular imaging.

"Uniting Siemens Nuclear Medicine with CTI to form a new molecular
imaging division supports our vision to be the innovation trendsetter
in the healthcare industry,” said Erich Reinhardt, Ph.D., president and CEO, Siemens Medical Solutions.

"CTI and Siemens are two pioneering companies in the healthcare technology field,” said Ronald Nutt, Ph.D., founder and former president and CEO of CTI Molecular Imaging, who is now the chief scientific advisor of the new Siemens division. "This new partnership marks an exciting step in our quest to discover and pursue new paths in molecular medicine, and reflects our overall strategy to personalize healthcare and positively impact the way illness is identified and treated.”





Related Links:
Siemens Medical Solutions
CTI Molecular Imaging
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Biopsy Software
Affirm® Contrast
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Portable X-ray Unit
AJEX140H

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.